Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
DOWNLOAD WHITEPAPER

Solid Formulation of a Recombinant Anthrax Vaccine

Pfenex and Glide Pharma have an ongoing collaboration to develop an anthrax vaccine containing the recombinant protective antigen (rPA) from Bacillus anthracis produced using Pfēnex expression technology, which is suitable for delivery with the Glide SDI (solid dose injection) technology.

This approach will address two important logistical constraints of the currently available vaccine, namely, long term stability during storage at room temperature and ease of administration.

Download to find out more.



Download to find out more.

Close
Close
Close

Go Top